David Sidransky - Jan 19, 2023 Form 4 Insider Report for Ayala Pharmaceuticals, Inc. (ADXS)

Role
Director
Signature
/s/ David Sidransky
Stock symbol
ADXS
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
4
Date filed
1/23/2023, 05:19 PM
Previous filing
Dec 29, 2022
Next filing
Nov 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADXS Common Stock Award +46 46 Jan 19, 2023 Held by Reporting Person's Son F1
holding ADXS Common Stock 93 Jan 19, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADXS Stock Option Award +2.34K 2.34K Jan 19, 2023 Common Stock 2.34K $55.23 Direct F2, F3
transaction ADXS Stock Option Award +2.34K 2.34K Jan 19, 2023 Common Stock 2.34K $8.70 Direct F4, F5
holding ADXS Stock Option 17 Jan 19, 2023 Common Stock 17 $16,128.00 Direct F2
holding ADXS Stock Option 42 Jan 19, 2023 Common Stock 42 $15,372.00 Direct F2
holding ADXS Stock Option 25 Jan 19, 2023 Common Stock 25 $9,252.00 Direct F2
holding ADXS Stock Option 25 Jan 19, 2023 Common Stock 25 $3,828.00 Direct F2
holding ADXS Stock Option 25 Jan 19, 2023 Common Stock 25 $648.00 Direct F2
holding ADXS Stock Option 125 Jan 19, 2023 Common Stock 125 $24.80 Direct F2
holding ADXS Stock Option 163 Jan 19, 2023 Common Stock 163 $52.80 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in exchange for 250 shares of the common stock of Ayala Pharmaceuticals, Inc. ("Old Ayala") in the merger of Old Ayala into the Issuer (the "Merger"). On the day prior to the effective date of the Merger, the closing price of Old Ayala's common stock was $0.53 per share, and the closing price of the Issuer's common stock was $2.95 per share.
F2 This option is fully vested and exercisable.
F3 Received in the Merger in exchange for an employee stock option to acquire 12,500 shares of the common stock of Old Ayala for $10.35 per share.
F4 This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.
F5 Received in the Merger in exchange for an employee stock option to acquire 12,500 shares of the common stock of Old Ayala for $1.63 per share.
F6 Two-thirds of this award is currently vested and the remaining one-third will be vested on May 4, 2023.